A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
Review on Non-alcoholic Fatty Liver Disease: Pathogenesis, Management and Treatment
2020
American Journal of PharmTech Research
Non-alcoholic fatty liver disease (NAFLD) is a metabolic syndrome and major chronic liver disease that can lead to liver cirrhosis, liver cancer and ultimately death. Although its progression rate may be slower than that other types of liver disease and the incidence of which is rising rapidly due to the increasing epidemic of obesity in both children and adults, worldwide. The accumulation of fat followed by subsequent inflammation is central to the development of liver injury, and is
doi:10.46624/ajptr.2020.v10.i1.015
fatcat:rkhatr5snbdgvizjkwqch3fdki